Tens of thousands of Hongkongers prescribed a common blood pressure drug recalled last month have been advised to continue taking it – despite patients having a one in 5,000 risk of developing cancer.
Medical experts said on Saturday that patients should not stop taking the recalled drug without consulting doctors, as the risk, assessed by the European Medicines Agency in its latest announcement, was not immediate and less than that involved if the patients stopped...
↧